Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

drug reimbursement

- PMLiVE

Sanofi alerts US authorities over bribery allegations

Concerns raised by anonymous whistleblower

Turkey’s pharma market is ripe for profitability

But will the highly efficient market be hindered by the government price referencing system?

China flag thumb

Sanofi opens new Shanghai R&D headquarters

China-based hub for Asia Pacific will create 1,400 jobs

Roche's Perjeta pertuzumab

Roche’s Perjeta should be ‘new standard’ in breast cancer

Could improve survival when added to therapy with Herceptin and docetaxel

- PMLiVE

The price is right: drug reimbursement in Europe

EFPIA's director general argues that drug pricing is not a gameshow

- PMLiVE

Humira gets FDA nod for paediatric Crohn’s disease

Can be used as treatment for patients as young as six

National Institute for Health and Care Excellence NICE logo

Remicade, Humira and Simponi face NICE knock-back

Draft guidance does not recommend the drugs for ulcerative colitis

- PMLiVE

GSK fined $487m as Chinese probe concludes

Five former executives receive jail sentences

- PMLiVE

Avastin safe in eye disease, says Cochrane

Recommends off-label use of Roche drug as cheaper alternative to Novartis’ Lucentis

- PMLiVE

Germany’s IQWiG denies Astellas’ incontinence drug

But Janssen receives recommendation for hepatitis C treatment Olysio

- PMLiVE

NICE wants more data on Boehringer’s Jardiance

Pharma company needs to demonstrate cost-effectiveness of its diabetes drug

Easier access to medicines in the UK?

Cutting through the NICE value-based assessment consultation to find out what’s at stake

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links